Illimis Therapeutics
Seoul, South Korea · Biotechnology, Health Care, Therapeutics
Illimis Therapeutics is a biotechnology company focused on developing therapeutics for CNS and immune diseases using its innovative GAIA platform. The company aims to create next-generation treatment options for neuro-immune diseases, addressing high unmet medical needs. Illimis actively engages in partnerships with global pharmaceutical companies and research institutions to enhance its drug deve
Key facts
- Headquarters
- Seoul, South Korea
- Employees
- 20
- Industries
- Biotechnology, Health Care, Therapeutics
- Status
- Private
- Website
- illimistx.com
- Company page
Recent activity at Illimis Therapeutics
Illimis Therapeutics funding history
| Date | Round | Amount |
|---|---|---|
| Jul 2025 | Series B | $42.0M |
Leadership
- Jin Lee, Vice President
- Sanghoon Park, Founder
Verified email and direct lines for Illimis Therapeutics’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Illimis Therapeutics in the news
Companies similar to Illimis Therapeutics
- Aerska · Biotechnology, Health Care, Therapeutics
- Rejuvenation Technologies · Biotechnology, Health Care, Therapeutics
- BIOVIE INC. · Biotechnology, Health Care, Therapeutics
- Lifesenz Cancer Research Labs Private Limited · Biotechnology, Health Care, Therapeutics
- Tessera Defense & Homeland Security Inc. · Biotechnology, Health Care, Therapeutics
About Illimis Therapeutics: questions and answers
What does Illimis Therapeutics do?
Illimis Therapeutics is a biotechnology company focused on developing therapeutics for CNS and immune diseases using its innovative GAIA platform. The company aims to create next-generation treatment options for neuro-immune diseases, addressing high unmet medical needs. Illimis actively engages in partnerships with global pharmaceutical companies and research institutions to enhance its drug deve
Where is Illimis Therapeutics headquartered?
Illimis Therapeutics is headquartered in Seoul, South Korea.
How many employees does Illimis Therapeutics have?
Illimis Therapeutics has about 20 employees.
Has Illimis Therapeutics raised funding?
Yes. Fundz has recorded 1 funding event for Illimis Therapeutics. The most recent, Series B of $42.0M, was in Jul 2025.
Who leads Illimis Therapeutics?
Jin Lee is a Vice President at Illimis Therapeutics.
What is the latest news on Illimis Therapeutics?
On Jul 16, 2025, Ilimis Therapeutics forms partnership with Lilly to enhance development of GAIA-based Alzheimer's therapies.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy